All Categories

Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis

Hosam F. Ahmed, Amalia Guzman-Gomez, Malika Desai, Alia Dani, David Morales, Paul J. Critser, Farhan Zafar, Don HayesCincinnati Children’s Hospital Medical Center.United States Research SquareRes Sq 2023; DOI: 10.21203/rs.3.rs-3310701/v1 AbstractBackground: Pulmonary vascular disease (PVD) represents an important clinical indication for lung transplant (LTx) in infants, children, and adolescents. There is limited information on LTx outcomes in these […]

Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis Read More »

Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction

Anna N. Seale, Hideki Uemura, Steven A. Webber, John Partridge, Michael Roughton, Siew Y. Ho, Karen P. McCarthy, Sheila Jones, Lynda Shaughnessy, Jan Sunnegardh, Katarina Hanseus, Hakan Berggren, Sune Johansson, Michael L. Rigby, Barry R. Keeton,Piers E. F. Daubeney on behalf of the British Congenital Cardiac AssociationRoyal Brompton Hospital, National Heart and Lung Institute and

Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction Read More »

Concentric placement of stents to relieve an obstructed anomalous pulmonary venous connection

John D. Coulson, Charles A. BullaboyChildren’s Hospital of The King’s Daughters.United States Catheterization and Cardiovascular DiagnosisCatheter Cardiovasc Diagn 1997; 42: 201-204DOI: 10.1002/(sici)1097-0304(199710)42:2<201::aid-ccd24>3.0.co;2-p AbstractA 9-month-old male with asplenia and complex congenital heart disease experienced progressive stenosis of an anomalous pulmonary venous connection. He developed pulmonary edema and growth failure. Two stents were placed concentrically to relieve the

Concentric placement of stents to relieve an obstructed anomalous pulmonary venous connection Read More »

Early and long-term results for correction of total anomalous pulmonary venous drainage (TAPVD) in neonates and infants

N. Sinzobahamvya, C. Arenz, A. M. Brecher, H. C. Blaschczok, A. E. UrbanJohanniter Kinderklinik.Germany European Journal of Cardiothoracic SurgeryEur J Cardiothorac Surg 1996; 10: 433-438DOI: 10.1016/s1010-7940(96)80111-4 AbstractObjective: To present our 17-year experience of surgical repair of total anomalous pulmonary venous drainage (TAPVD) in 71 consecutive neonates and infants, with particular emphasis on the role of preoperative pulmonary

Early and long-term results for correction of total anomalous pulmonary venous drainage (TAPVD) in neonates and infants Read More »

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan

Emi Matsugi, Shigeki Takashima, Shuhei Doteguchi, Tomomi Kobayashi, Motohiro OkayasuMallinckrodt Pharmaceuticals. Japan General Thoracic and Cardiovascular SurgeryGen Thorac Cardiovasc Surg 2023; DOI: 10.1007/s11748-023-01971-2 AbstractObjective: To evaluate the real-world safety and effectiveness of inhaled nitric oxide (INOflo® for Inhalation 800 ppm) for perioperative pulmonary hypertension associated with cardiac surgery in Japan.Methods: This was a prospective, non-interventional, all-case, post-marketing study of

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan Read More »

Dual-energy computed tomography to detect early pulmonary vascular changes in children with sickle cell disease: a pilot study

Raphael Joye, Julie Wacker, Duy-Anh Nguyen, Anne-Lise Hachulla, Albane B. R. Maggio, Laurent Cimasoni, Frederic Lador, Marc Ansari, Maurice BeghettiGeneva University Hospitals and University of Geneva.Switzerland Frontiers in PediatricsFront Pediatr 2023; 11DOI: 10.3389/fped.2023.1221977 AbstractIntroduction: Pulmonary hypertension (PH) is a rare but fatal complication of sickle cell disease (SCD) that is possibly reversible if treated early. Dual-energy computed

Dual-energy computed tomography to detect early pulmonary vascular changes in children with sickle cell disease: a pilot study Read More »

Congenitally absent pulmonary veins–diagnostic pitfalls. Two case reports

P. L. Van der Merwe, N. N. Kalis, R. P. Gie, M. Dumoulin, M. GewilligUniversity of Stellenbosch and Tygerberg Hospital.South Africa South African Medical JournalSo Afr Med J 1996; 86 Suppl 3: C137-C141DOI: Not Available AbstractTwo patients with partial absence of the right and left pulmonary veins respectively are described. Congenitally absent pulmonary veins are

Congenitally absent pulmonary veins–diagnostic pitfalls. Two case reports Read More »

Long-term results after surgical repair of total anomalous pulmonary venous connection–hemodynamic evaluation of pulmonary venous obstruction with isoproterenol infusion

Hidetoshi Fujino, Makoto Nakazawa, Kazuo Momma, Yasuharu ImaiTokyo Women’s Medical College.Japan Japan Circulation JournalJpn Circ J 1995; 59: 198-204DOI: 10.1253/jcj.59.198 AbstractTo evaluate late pulmonary venous obstruction following surgical repair in patients with total anomalous pulmonary venous connection, which may be disclosed at high cardiac output but not at rest, a hemodynamic study was performed using isoproterenol

Long-term results after surgical repair of total anomalous pulmonary venous connection–hemodynamic evaluation of pulmonary venous obstruction with isoproterenol infusion Read More »

Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants

Matthew F. Pizzuto, Matthew M. Laughon, Wesley M. JacksonUniversity of North Carolina at Chapel Hill.United States Expert Opinion on PharmacotherapyExpert Opin Pharmacother 2023; DOI: 10.1080/14656566.2023.2257598 AbstractIntroduction: Pulmonary hypertension (PH) is a complex condition that encompasses an array of underlying disease processes and affects a diverse population of infants, including those with congenital heart disease, congenital diaphragmatic hernia,

Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants Read More »

Pulmonary Venous Gradients in Healthy Controls and Following the Repair of Total Anomalous Pulmonary Venous Return

Michael F. Swartz, Cecilia Meagher, Shuichi Yoshitake, Nader Atallah-Yunes, Ron Angona, Jill M. Cholette, George M. AlfierisPediatric Cardiac Consortium of Central New York. University of Rochester Medical Center. United States Pediatric CardiologyPediatr Cardiol 2023; 44: 325-332DOI: 10.1007/s00246-022-02986-x AbstractThe percent of children who can achieve a normal and physiologic pulmonary venous gradient and flow following the repair

Pulmonary Venous Gradients in Healthy Controls and Following the Repair of Total Anomalous Pulmonary Venous Return Read More »

Scroll to Top